These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14492054)

  • 1. [Observations on the effect of the aldosterone antagonist spironolactone (aldactone) in normal and toxemic pregnancy (preliminary report)].
    RICHTER RH; ARNOLD M
    Gynaecologia; 1961; 152():248-57. PubMed ID: 14492054
    [No Abstract]   [Full Text] [Related]  

  • 2. [Our experiences with the aldosterone blocking agent, aldactone in obstetrics].
    STARK G
    Geburtshilfe Frauenheilkd; 1962 Feb; 22():155-61. PubMed ID: 13916310
    [No Abstract]   [Full Text] [Related]  

  • 3. [Observations on the use of an aldosterone antagonist (aldactone) in the therapy of water retention].
    GHIRINGHELLI L; COMOLI G
    Minerva Med; 1962 Jun; 53():1760-3. PubMed ID: 13898209
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic acquisitions. Spironolactone (aldactone)].
    COSTA R
    Maroc Med; 1962 Apr; 41():425-6. PubMed ID: 13881592
    [No Abstract]   [Full Text] [Related]  

  • 5. [Spirolactones (Aldactone)].
    PERRAULT M
    Rev Prat; 1961 Dec; 11():3439-46. PubMed ID: 14485478
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aldosterone-antagonistic spirolactones. Principles for their indication and use].
    KOCZOREK KR
    Internist (Berl); 1961 Nov; 2():640-54. PubMed ID: 14457621
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aldactone (aldosterone antagonist SC-9, 420) in the treatment of the edemas of heart patients and cirrhotic patients. Bioclinical study].
    PAGET M; LANGERON L; CROCCEL L; ROUTIER G; CROCCEL E; PROTIN M
    J Sci Med Lille; 1962 May; 80():225-35. PubMed ID: 14483183
    [No Abstract]   [Full Text] [Related]  

  • 8. Spironolactone in hypertensive patients. Oligemic and antihypertensive effects.
    GEORGOPOULOS AJ; DUSTAN H; PAGE IH
    Arch Intern Med; 1961 Sep; 108():389-92. PubMed ID: 13704490
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of spirolactone SC-9420 "Aldactone"].
    KUCHEL O; HORKY K; DONOCIK A
    Cas Lek Cesk; 1962 Jul; 101():962-7. PubMed ID: 14460149
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diuretic and saluretic action of an aldosterone antagonist (spirolactone, SC-9420) associated with an iso-indoline derivative (Hygroton) in refractory cardiac edema].
    STRATA A; PREIS H
    Boll Soc Ital Cardiol; 1962; 7():106-14. PubMed ID: 13917659
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aldosterone-antagonistic spirolactones. II. Clinical aspects].
    HILD R; KRUECK F
    Klin Wochenschr; 1961 Feb; 39():178-81. PubMed ID: 13714208
    [No Abstract]   [Full Text] [Related]  

  • 12. [The aldosterone-antagonistic spirolactone. I. Pharmacology].
    KRUECK F; HILD R
    Klin Wochenschr; 1960 Oct; 38():962-5. PubMed ID: 13754545
    [No Abstract]   [Full Text] [Related]  

  • 13. [Spirolactone, an aldosterone-antagonistic steroid. Illustration of its effects on a patient with liver cirrhosis].
    EILERSEN P; HEMPEL-JORGENSEN P
    Ugeskr Laeger; 1960 Feb; 122():252-6. PubMed ID: 13819718
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of an aldosterone-antagonist (SC-8109) on radio-sodium (Na22) metabolism in rats with hypothalamic lesions.
    LUPULESCU A; NICOLESCU-CATARGIA ; NEACSUC
    Acta Biol Med Ger; 1961; 6():482-90. PubMed ID: 14467462
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aldactone (antialdosterone SC-9420) in the treatment of the edema of cardiac and cirrhoticpatients. Bioclinical study. I].
    PAGET M; LANGERON L; CROCCEL L; ROUTIER G; CROCCEL E
    Ann Biol Clin (Paris); 1962; 20():497-524. PubMed ID: 14483184
    [No Abstract]   [Full Text] [Related]  

  • 16. [RENAL CLEARANCE OF FREE ALDOSTERONE BEFORE AND AFTER APPLICATION OF AN ALDOSTERONE ANTAGONIST].
    GFELLER J
    Z Gesamte Exp Med; 1964 Oct; 138():353-65. PubMed ID: 14316605
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of aldosterone antagonist (SC 9420) on periodic paralysis.
    OKINAKA S; OHSAWA N; SHIZUME K; MOTOHASHI K; FUJITA T; MURAKAWA S; MATSUZAKI F; MORII H; UCHIKAWA T
    J Clin Endocrinol Metab; 1962 May; 22():549-51. PubMed ID: 14481568
    [No Abstract]   [Full Text] [Related]  

  • 18. [A study of the natriuretic action of an antagonist of aldosterone: spirolactone SC 9420 (aldactone)].
    VEYRAT R; ENGEL E; DUCOMMUN P; MULLER AF
    Schweiz Med Wochenschr; 1960 Apr; 90():494-7. PubMed ID: 13842023
    [No Abstract]   [Full Text] [Related]  

  • 19. Spirolactone diuretics.
    WAY JL
    Wis Med J; 1961 Jul; 60():383. PubMed ID: 13783494
    [No Abstract]   [Full Text] [Related]  

  • 20. [The antiphlogistic effect and mechanism of action of spironolactone].
    HIEMEYER V; KAEHLER HJ
    Klin Wochenschr; 1962 Aug; 40():786-91. PubMed ID: 13907203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.